Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
24
TNDM Quote, Financials, Valuation and Earnings
Last price:
$18.63
Seasonality move
:
20.79%
Day range:
$18.08 - $19.10
52-week range:
$9.98 - $29.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.22x
P/B ratio:
8.12x
Volume:
1M
Avg. volume:
2.8M
1-year change:
-1.48%
Market cap:
$1.3B
Revenue:
$1B
EPS (TTM):
-$3.07
Analysts' Opinion
-
Consensus RatingTandem Diabetes Care, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 9 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $30.76, Tandem Diabetes Care, Inc. has an estimated upside of 65.3% from its current price of $18.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $18.61.
Fair Value
-
According to the consensus of 20 analysts, Tandem Diabetes Care, Inc. has 65.3% upside to fair value with a price target of $30.76 per share.
TNDM vs. S&P 500
-
Over the past 5 trading days, Tandem Diabetes Care, Inc. has underperformed the S&P 500 by -22.79% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Tandem Diabetes Care, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tandem Diabetes Care, Inc. has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Tandem Diabetes Care, Inc. reported revenues of $290.4M.
Earnings Growth
-
Tandem Diabetes Care, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tandem Diabetes Care, Inc. reported earnings per share of -$0.01.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
1.22x
EV / EBIT:
--
EV / Revenue:
1.41x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
-48.14x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$546M
Return On Assets:
-22.64%
Net Income Margin (TTM):
-20.17%
Return On Equity:
-121.88%
Return On Invested Capital:
-32.45%
Operating Margin:
2.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $747.7M | $940.2M | $1B | $282.6M | $290.4M | |
| Gross Profit | $367.7M | $489.6M | $546M | $157.5M | $167.5M | |
| Operating Income | -$154.5M | -$99.1M | -$89.3M | -$582K | $8.3M | |
| EBITDA | -$138.8M | -$82.5M | -$71.6M | $3.7M | $12.8M | |
| Diluted EPS | -$3.44 | -$1.47 | -$3.07 | $0.01 | -$0.01 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $811.5M | $850M | $748M | $724.5M | $618.1M | |
| Total Assets | $905.1M | $1.1B | $952.7M | $967.7M | $881.1M | |
| Current Liabilities | $131.9M | $165.3M | $195.3M | $247M | $242.7M | |
| Total Liabilities | $472M | $612.8M | $639M | $704.6M | $725.9M | |
| Total Equity | $433.1M | $439.9M | $313.6M | $263.1M | $155.2M | |
| Total Debt | $305.4M | $406.8M | $398.6M | $455.4M | $425M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$31.8M | $24.2M | -$9.7M | $10.7M | $9.8M | |
| Cash From Investing | -$85.7M | -$23.5M | $72.9M | $5M | -$15M | |
| Cash From Financing | $4.1M | $8.4M | -$43.4M | $2.3M | $2.6M | |
| Free Cash Flow | -$58.6M | $5M | -$29.7M | $7.6M | $3.1M | |
TNDM
Sector
Market Cap
$1.3B
$23.9M
Price % of 52-Week High
62.77%
47.44%
Dividend Yield
0%
0%
Shareholder Yield
0.53%
-1.88%
1-Year Price Total Return
-1.48%
-18.29%
Beta (5-Year)
1.737
0.513
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$21.16
200-day SMA
Buy
Level
$17.81
Bollinger Bands (100)
Sell
Level
18.98 - 23.5
Chaikin Money Flow
Buy
Level
53.7M
20-day SMA
Sell
Level
$22.10
Relative Strength Index (RSI14)
Sell
Level
33.41
ADX Line
Sell
Level
21.56
Williams %R
Buy
Level
-93.6145
50-day SMA
Sell
Level
$21.64
MACD (12, 26)
Sell
Level
-0.71
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
90.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6208)
Sell
CA Score
(Annual)
Level (-1.6718)
Sell
Beneish M-Score
(Annual)
Level (-1.6338)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.7867)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, TNDM has received 9 Buy ratings 11 Hold ratings, and 0 Sell ratings. The TNDM average analyst price target in the past 3 months is $30.76.
-
Where Will Tandem Diabetes Care, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tandem Diabetes Care, Inc. share price will rise to $30.76 per share over the next 12 months.
-
What Do Analysts Say About Tandem Diabetes Care, Inc.?
Analysts are divided on their view about Tandem Diabetes Care, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tandem Diabetes Care, Inc. is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is Tandem Diabetes Care, Inc.'s Price Target?
The price target for Tandem Diabetes Care, Inc. over the next 1-year time period is forecast to be $30.76 according to 20 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is TNDM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tandem Diabetes Care, Inc. is a Hold. 11 of 20 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TNDM?
You can purchase shares of Tandem Diabetes Care, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tandem Diabetes Care, Inc. shares.
-
What Is The Tandem Diabetes Care, Inc. Share Price Today?
Tandem Diabetes Care, Inc. was last trading at $18.63 per share. This represents the most recent stock quote for Tandem Diabetes Care, Inc.. Yesterday, Tandem Diabetes Care, Inc. closed at $18.61 per share.
-
How To Buy Tandem Diabetes Care, Inc. Stock Online?
In order to purchase Tandem Diabetes Care, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TNDM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TNDM
Sector
P/E ratio
--
21.37x
PEG ratio
-0.06x
-0.01x
P/B ratio
8.12x
1.72x
Price / LTM sales
1.22x
1.45x
Growth Metrics
TNDM
Sector
Revenue growth
2.74%
3.44%
Earnings growth
-176.32%
15.03%
Revenue (5-year growth)
15.26%
6.25%
Earnings forecast
-$0.44
-$0.22
Profitability
TNDM
Sector
Profitability FY 2025
$530.8M
$2.4M
Return on invested capital
-32.45%
-33.32%
Return on assets
-22.64%
-29.45%
Return on equity
-121.88%
-40.29%
Earnings Date
Last Earnings Date
Feb
19
Next Earnings Date
Apr
29
Estimated Next Earnings Date
May
21
Balance Sheet
TNDM
Sector
Total cash
$292.7M
$25.7M
Short term investments
$369.1M
$22.7M
Total assets
$881.1M
$70.6M
Long term debt
$425M
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
